Overview

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis

Status:
Not yet recruiting

Trial end date:
2023-07-02

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy of Combo compared to its individual components and compared to vehicle in a population of subjects with seasonal allergic conjunctivitis.

Phase:

Phase 3

Details

Lead Sponsor:

Bausch & Lomb Incorporated

Treatments:

Brimonidine Tartrate
Ketotifen
Ophthalmic Solutions
Pharmaceutical Solutions